Obsessive-Compulsive Disorder

OCD is a treatable condition. Most patients improve with therapy and medication. For the small subset with severe, treatment-resistant symptoms, neurosurgical options may be considered at specialized centers.

First-line: therapy & medication

Evidence-based psychotherapy (ERP) and medications (often SSRIs) are the standard starting point. Most patients improve with structured specialist care.

DBS for severe, refractory OCD

Deep brain stimulation is available under FDA Humanitarian Device Exemption for a small subset of adults with chronic, severe, treatment-resistant OCD.

Focused ultrasound under study

MRgFUS capsulotomy creates a permanent lesion without an incision or implant. For OCD, it remains investigational in the United States.

Understanding your condition

What is OCD?

Obsessive-compulsive disorder involves intrusive thoughts (obsessions) and repetitive behaviors or rituals (compulsions) that cause significant distress and impair daily life. It is more than being "neat" or "particular": OCD can be profoundly disabling when severe.

The good news is that OCD is treatable. Most patients improve with structured, specialist care. Neurosurgical options are considered only after extensive treatment trials have been carefully documented: this is a last-resort pathway for a very select group of patients.

The treatment pathway for OCD

ERP Therapy

Exposure and response prevention

Medications

SSRIs and augmentation strategies

Multiple Trials

Documented failure of evidence-based options

Neurosurgery

DBS or lesion procedure in select patients

Neurosurgical options are considered only after extensive, documented treatment trials: this is a highly selective pathway.

Am I a candidate?

Who may be a candidate for DBS or focused ultrasound?

Candidacy is highly selective and typically requires:

These criteria reflect the gravity of the decision: neurosurgery for OCD is a last-resort option after all established therapies have been fully explored.

  • Longstanding, severe OCD with major functional impairment affecting daily life, work, and relationships.
  • Documented failure of multiple evidence-based treatments, including multiple medication trials and specialty psychotherapy (ERP).
  • Multidisciplinary evaluation by psychiatry, psychology, and neurosurgery, with careful assessment of safety and realistic goals.
Your options

Treatment Options

Two neurosurgical approaches exist for treatment-resistant OCD. The key decision is often between adjustable neuromodulation and permanent lesioning: each with distinct tradeoffs.

Neuromodulation

Deep Brain Stimulation (DBS)

Adjustable stimulation of the anterior limb of the internal capsule

How it works Electrodes implanted in the brain deliver electrical stimulation to a target in the cortico-striatal-thalamic circuit. A programmable generator is placed under the skin.
FDA status The specific OCD DBS device has a Humanitarian Device Exemption (HDE) for adults with chronic, severe, treatment-resistant OCD after failure of at least three SSRIs, as an adjunct to medication and an alternative to anterior capsulotomy.
Key advantage Stimulation can be adjusted or turned off. Implantation and removal require surgery, and some complications may be lasting. Long-term follow-up is required.
Timeline Improvement may require months of careful programming adjustments in collaboration with psychiatry.
Adjustable Can be turned off FDA HDE Programmable
Lesion procedure

Focused Ultrasound Capsulotomy

Incisionless MRI-guided lesion targeting OCD circuitry

How it works MR-guided focused ultrasound (MRgFUS) creates a targeted lesion in a circuit relevant to OCD and depression, without a brain incision or implanted device.
Current status MRgFUS capsulotomy for OCD remains investigational in the United States. It is not an FDA-approved OCD treatment; access requires evaluation within an appropriate research setting.
Key distinction Creates a permanent lesion, no implant, no programming, but also not adjustable or reversible once delivered.
Follow-up Close monitoring for mood, anxiety changes, and neurologic effects is essential after the procedure.
Incisionless No implant Permanent Investigational

The Key Decision: Adjustable vs. Permanent

For OCD neurosurgery, the central question is often adjustable neuromodulation (DBS) versus permanent lesioning (focused ultrasound or radiosurgical capsulotomy). Dual expertise across functional neurosurgery and radiation planning supports nuanced counseling on targets, expected timelines, and risk tradeoffs: helping you make a fully informed decision.

Your journey

What to Expect

Both pathways begin with a thorough process to confirm treatment resistance and ensure you're making an informed decision.

Before

Confirm treatment resistance through detailed review of prior therapies. Comprehensive psychiatric evaluation and shared decision-making to compare DBS versus lesioning approaches, including targets, timelines, and tradeoffs.

During & After

DBS pathway

Surgery to place electrodes and generator, followed by staged programming visits. Symptom improvement may require months of careful adjustments in close collaboration with psychiatry.

MRgFUS pathway

Incisionless MRI-based procedure completed in a single session. Close follow-up for mood and anxiety changes, cognitive effects, and neurologic monitoring.

Long-term

Ongoing psychiatric care continues regardless of which approach is chosen. Neurosurgery for OCD is always an adjunct to, not a replacement for, continued mental health treatment.

Weighing your options

Benefits and Risks

Potential Benefits

  • Meaningful symptom reduction in highly selected patients
  • Potential improvement in daily function and quality of life
  • DBS stimulation can be adjusted or turned off
  • MRgFUS avoids an incision and implanted hardware

Possible Risks

DBS

  • Temporary mood or sleep changes, discomfort at implant sites, need for reprogramming
  • Bleeding, infection: standard surgical risks

Focused ultrasound

  • Headache, temporary neurologic or cognitive effects
  • Unintended lesion effects, hemorrhage, or persistent cognitive/behavioral changes
Common questions

Patient FAQs

Is DBS "approved" for OCD?
A specific DBS device is authorized through the FDA Humanitarian Device Exemption (HDE) pathway for selected adults with chronic, severe, treatment-resistant OCD after failure of at least three SSRIs. Treatment supplements medication and is an alternative to anterior capsulotomy. HDE authorization is based on safety and probable benefit; it does not require the same demonstration of effectiveness as conventional device approval. Institutional oversight is required. FDA indication.
How soon will I feel better?
Improvement is often gradual and requires careful programming (for DBS) and ongoing psychiatric follow-up over months. This is not a quick fix, but for the right patients, the long-term results can be meaningful.
Is focused ultrasound reversible?
No: focused ultrasound capsulotomy creates a permanent lesion. There is no implant to remove or turn off. This is one of the most important differences between DBS and lesioning approaches, and it's a key part of the decision-making process.

Last updated September 23, 2026.

When to Seek Emergency Care

Call 911 in the United States, or your local emergency number elsewhere, now for sudden weakness or numbness on one side; new trouble speaking, seeing, walking, or staying awake; loss of consciousness; trouble breathing; a first seizure; a seizure lasting 5 minutes or longer; repeated seizures without recovery; a seizure with serious injury or in water; or a sudden, severe headache. If you have epilepsy, follow your seizure action plan when it applies.

For suicidal thoughts or a mental-health crisis, call or text 988 in the United States. If there is immediate danger, call 911.

Contact your care team today for fever, wound redness or drainage, medication side effects, worsening pain, new balance or sensory symptoms, or other concerns that are not immediately life-threatening.